Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

SAGETRACK

Sign In to gain access to subscriptions and/or personal tools.
Medical Decision Making
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Black, W. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Black, W. C.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The CE Plane

A Graphic Representation of Cost-Effectiveness

William C. Black, MD

The concept of cost-effectiveness is illustrated graphical on the CE plane. Strategies are represented according to their effectiveness (e) and cost (c) relative to those of some reference standard. A straight line with slope K passes through the origin, where K is the maximum acceptable cost-effectiveness ratio. Strategies plotted to the right of line K are cost-effective, while those plotted to the left are not. Furthermore, the most cost-effective of two or more mutually exclusive alternatives is that plotted the greatest distance to the right of K. The CE plane can be used to resolve ambiguities about the meaning of cost-effec tiveness and to illustrate its relevance to medical decision making. Key words: CE plane; cost-effectiveness. (Med Decis Making 1990;10:212-214)

Medical Decision Making, Vol. 10, No. 3, 212-214 (1990)
DOI: 10.1177/0272989X9001000308
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 RadiologyHome page
C. L. Sistrom
The Appropriateness of Imaging: A Comprehensive Conceptual Framework
Radiology, June 1, 2009; 251(3): 637 - 649.
[Abstract] [Full Text] [PDF]

Home page
 Arch Gen PsychiatryHome page
C. A. G. Wolfs, C. D. Dirksen, A. Kessels, J. L. Severens, and F. R. J. Verhey
Economic Evaluation of an Integrated Diagnostic Approach for Psychogeriatric Patients: Results of a Randomized Controlled Trial
Arch Gen Psychiatry, March 1, 2009; 66(3): 313 - 323.
[Abstract] [Full Text] [PDF]

Home page
 Med Decis MakingHome page
S. Eckermann, A. Briggs, and A. R. Willan
Health Technology Assessment in the Cost-Disutility Plane
Med Decis Making, March 1, 2008; 28(2): 172 - 181.
[Abstract] [PDF]

Home page
 Clin. Chem.Home page
T. Breidthardt, K. Laule, A.-H. Strohmeyer, C. Schindler, S. Meier, M. Fischer, A. Scholer, M. Noveanu, M. Christ, A. P. Perruchoud, et al.
Medical and Economic Long-term Effects of B-Type Natriuretic Peptide Testing in Patients with Acute Dyspnea
Clin. Chem., August 1, 2007; 53(8): 1415 - 1422.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
A. Ebri, H. Kuper, and S. Wedner
Cost-Effectiveness of Cycloplegic Agents: Results of a Randomized Controlled Trial in Nigerian Children
Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1025 - 1031.
[Abstract] [Full Text] [PDF]

Home page
 Med Decis MakingHome page
B. Groot Koerkamp, M.G. M. Hunink, T. Stijnen, J. K. Hammitt, K. M. Kuntz, and M. C. Weinstein
Limitations of Acceptability Curves for Presenting Uncertainty in Cost-Effectiveness Analysis
Med Decis Making, March 1, 2007; 27(2): 101 - 111.
[Abstract] [PDF]

Home page
 Clin TrialsHome page
A. M Gray
Cost-effectiveness analyses alongside randomised clinical trials
Clinical Trials, December 1, 2006; 3(6): 538 - 542.
[Abstract] [PDF]

Home page
 ChestHome page
A. O. D'Souza, M. J. Smith, L. A. Miller, and J. Kavookjian
An Appraisal of Pharmacoeconomic Evidence of Maintenance Therapy for COPD
Chest, June 1, 2006; 129(6): 1693 - 1708.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
C. Mueller, K. Laule-Kilian, C. Schindler, T. Klima, B. Frana, D. Rodriguez, A. Scholer, M. Christ, and A. P. Perruchoud
Cost-effectiveness of B-Type Natriuretic Peptide Testing in Patients With Acute Dyspnea.
Arch Intern Med, May 22, 2006; 166(10): 1081 - 1087.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
S. Petrou, M. Bischof, C. Bennett, D. Elbourne, D. Field, and H. McNally
Cost-Effectiveness of Neonatal Extracorporeal Membrane Oxygenation Based on 7-Year Results From the United Kingdom Collaborative ECMO Trial
Pediatrics, May 1, 2006; 117(5): 1640 - 1649.
[Abstract] [Full Text] [PDF]

Home page
 Med Decis MakingHome page
S. G. Thompson and R. M. Nixon
How Sensitive Are Cost-Effectiveness Analyses to Choice of Parametric Distributions?
Med Decis Making, July 1, 2005; 25(4): 416 - 423.
[Abstract] [PDF]

Home page
 Fam PractHome page
N. H Williams, R. T Edwards, P. Linck, R. Muntz, R. Hibbs, C. Wilkinson, I. Russell, D. Russell, and B. Hounsome
Cost-utility analysis of osteopathy in primary care: results from a pragmatic randomized controlled trial
Fam. Pract., December 1, 2004; 21(6): 643 - 650.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
D. A. Marshall, A. R. Levy, H. Vidaillet, E. Fenwick, A. Slee, G. Blackhouse, H. L. Greene, D. G. Wyse, G. Nichol, B. J. O'Brien, et al.
Cost-Effectiveness of Rhythm versus Rate Control in Atrial Fibrillation
Ann Intern Med, November 2, 2004; 141(9): 653 - 661.
[Abstract] [Full Text] [PDF]

Home page
 Med Decis MakingHome page
A. P. Johnson-Masotti, P. W. Laud, R. G. Hoffmann, M. J. Hayat, and S. D. Pinkerton
A Bayesian Approach to Net Health Benefits: An Illustration and Application to Modeling HIV Prevention
Med Decis Making, November 1, 2004; 24(6): 634 - 653.
[Abstract] [PDF]

Home page
 Stat Methods Med ResHome page
B J O'Brien and A H Briggs
Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods
Statistical Methods in Medical Research, December 1, 2002; 11(6): 455 - 468.
[Abstract] [PDF]

Home page
 Stat Methods Med ResHome page
A O'Hagan and J W Stevens
Bayesian methods for design and analysis of cost-effectiveness trials in the evaluation of health care technologies
Statistical Methods in Medical Research, December 1, 2002; 11(6): 469 - 490.
[Abstract] [PDF]

Home page
 Eval RevHome page
A. P. Johnson-Masotti, P. W. Laud, R. G. Hoffmann, M. J. Hayat, and S. D. Pinkerton
Probabilistic Cost-Effectiveness Analysis of HIV Prevention: Comparing a Bayesian Approach With Traditional Deterministic Sensitivity Analysis
Eval Rev, August 1, 2001; 25(4): 474 - 502.
[Abstract] [PDF]

Home page
 Med Decis MakingHome page
A. H. Briggs and A. M. Gray
Power and Sample Size Calculations for Stochastic Cost-Effectiveness Analysis
Med Decis Making, April 1, 1998; 18(2): S81 - S92.
[Abstract] [PDF]

Home page
 Med Decis MakingHome page
T. G. Ganiats
Cost - Effectiveness Concepts and the CE Plane
Med Decis Making, June 1, 1991; 11(2): 147 - 147.
[PDF]

Home page
 Med Decis MakingHome page
W. C. Black
In reply
Med Decis Making, June 1, 1991; 11(2): 147 - 147.
[PDF]